Engineered Cell Therapy Research
Research into engineered and adoptive cell therapies including IgE-sensitized mast cells, NK cell therapy, and next-generation CAR-T approaches for solid tumors.
Key Mechanisms
- IgE-mediated mast cell activation for tumor targeting
- Allogeneic NK cell expansion and infusion
- Armored CAR-T with cytokine secretion
- Tumor microenvironment remodeling
Notable Compounds
- IgE-sensitized mast cells
- Expanded NK cells
- Bi-specific CAR-T constructs
- TIL (tumor-infiltrating lymphocyte) therapy